Results 191 to 200 of about 6,318,434 (307)

Developing evidence‐based, cost‐effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities

Molecular Oncology, EarlyView.
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg, Joachim von Braun, Julio Celis, Anton Berns, Michael Baumann, Tit Albreht, Nancy Abou‐Zeid, Vanderlei Bagnato, Christian Brandts, Chien‐Jen Chen, Massimiliano di Pietro, Manjit Dosanjh, Thomas Dubois, Alexander Eggermont, Angelika Eggert, Ingemar Ernberg, Sara Faithfull, Johannes Förner, Stefan Fröhling, Manuel Heitor, Leroy Hood, Wei Jiang, Bengt Jönsson, Ravi Kannan, Maria Leptin, Su Li, Peter Lindgren, Douglas Lowy, Jun Ma, Alex Markham, Péter Nagy, Simon Oberst, M. Iqbal Parker, Danielle Rodin, Kevin Ryan, Joachim Schüz, Richard Sullivan, Josep Tabernero, Peter Turkson, Oliver Várhelyi, Harold Varmus, Chijie Wang, Elisabete Weiderpass, Nils Wilking   +43 more
wiley   +1 more source

Differences in GenBank and RefSeq annotations may affect genomics data interpretation for <i>Pseudomonas putida</i> KT2440. [PDF]

mSphere
de Siqueira GMV, Eng T, Mukhopadhyay A, Guazzaroni M-E.   +3 more
europepmc   +1 more source

Potential pitfalls in analysing a SARS-CoV-2 RT-PCR assay and how to standardise data interpretation. [PDF]

J Virol Methods, 2022
Smith M, El Bouzidi K, Bengen S, Cohen A, Zuckerman M.   +4 more
europepmc   +1 more source

Visual interpretation of ASTER satellite data, Part II: Land use mapping in Mpumalanga,South Africa

, 2007
Elna Van Niekerk
openalex   +2 more sources

PARP inhibition and pharmacological ascorbate demonstrate synergy in castration‐resistant prostate cancer

Molecular Oncology, EarlyView.
Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon, Peter T. Gallagher, Orly I. Richter, Neermala Poudel Neupane, Amy C. Mandigo, Jennifer J. McCann, Emanuela Dylgjeri, Irina Vasilevskaya, Christopher McNair, Channing J. Paller, Wm. Kevin Kelly, Karen E. Knudsen, Matthew J. Schiewer, Ayesha A. Shafi   +13 more
wiley   +1 more source

Clarifying data interpretation and therapeutic classification in ADC clinical trials for lung cancer. [PDF]

Int J Surg
Sun M, Zang D, Chen J.
europepmc   +1 more source

MOMA: a multi-task attention learning algorithm for multi-omics data interpretation and classification. [PDF]

Bioinformatics, 2022
Moon S, Lee H.
europepmc   +1 more source

Measuring and Modeling of P- and S-Wave Velocities on Crustal Rocks: A Key for the Interpretation of Seismic Reflection and Refraction Data [PDF]

, 2011
H. Kern
openalex   +1 more source

LDAcoop: Integrating non‐linear population dynamics into the analysis of clonogenic growth in vitro

Molecular Oncology, EarlyView.
Limiting dilution assays (LDAs) quantify clonogenic growth by seeding serial dilutions of cells and scoring wells for colony formation. The fraction of negative wells is plotted against cells seeded and analyzed using the non‐linear modeling of LDAcoop.
Nikko Brix, Daniel Samaga, Katharina Gehr, Benedek Dankó, Mohamed Schumann, Guido Drexler, Ahmed Alnatsha, Georg Beyer, Ujjwal Mahajan, Martin Selmansberger, Julia Mayerle, Claus Belka, Horst Zitzelsberger, Kirsten Lauber   +13 more
wiley   +1 more source

Correction: MWENA: a novel sample re-weighting-based algorithm for disease classification and data interpretation using extracellular vesicles omics data. [PDF]

BMC Genomics
Liao S, Long H, Zhu Q, Li S, Li L, Lu S, Tang N, Liang Y, Dong M.   +8 more
europepmc   +1 more source